OTC Market Tier: OTCQX International
International Reporting: TSX Venture Exchange
Audited Financials: Audited
Medifocus is a medical device company which owns a patented microwave focusing technology platform, the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation.
Home Country News Releases: http://www.otcmarkets.com/stock/MDFZF/news